Quarterly Results

MYLAN LABORATORIES LTD.

NSE : NABSE : 524794ISIN CODE : INE604D01023Industry : Pharmaceuticals & DrugsHouse : MNC
BSE209.350 (0 %)
PREV CLOSE ( ) 209.35
OPEN PRICE ( ) 208.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 209.35 (2)
VOLUME 50392
TODAY'S LOW / HIGH ( )208.80 211.00
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Mar 2009
Dec 2008
Sep 2008
Jun 2008
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
6472.1
5816.4
5224.9
5408
Total Expenditure
5673.6
5365
3930.3
4813.4
PBIDT (Excl OI)
798.5
451.4
1294.6
594.6
Other Income
52.2
46.7
92.9
65.4
Operating Profit
850.7
498.1
1387.5
660
Interest
360.3
410.4
394.6
305.7
Exceptional Items
535.9
0.00
-535.9
NA
PBDT
1026.3
87.7
457
354.3
Depreciation
195.5
178.3
163.2
163.6
Profit Before Tax
830.8
-90.6
293.8
190.7
Tax
315.4
224.4
187.2
151.4
Provisions and contingencies
0.00
NA
NA
NA
Profit After Tax
515.4
-315
106.6
39.3
Extraordinary Items
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
NA
NA
NA
Other Adjustments
0.00
NA
NA
NA
Net Profit
515.4
-315
106.6
39.3
Minority Interest
-19.7
-16.9
-4.9
-2.1
Shares of Associates
7.3
2.7
-12.8
0
Other related items
0
0
0
Misc. Expenses Written off
0.00
NA
NA
NA
Consolidated Net Profit
503
-329.2
88.9
37.2
Equity Capital
309.2
309.2
309.2
309.2
Face Value (IN RS)
2
2
2
2
Reserves
6217.5
0.00
0.00
0.00
Calculated EPS
3.33
-2.03
0.68
0.25
Calculated EPS (Annualised)
13.33
-8.15
2.75
1.01
No of Public Share Holdings
36911189
36910189
36903471
36903471
% of Public Share Holdings
23.87
23.87
23.87
23.87
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
12.33
7.76
24.77
10.99
PBIDTM%
13.14
8.56
26.55
12.20
PBDTM%
15.85
1.50
8.74
6.55
PBTM%
12.83
-1.55
5.62
3.52
PATM%
7.96
-5.41
2.04
0.72
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)